News

Filter

All All Features Interviews Portfolio news

What startups need to know about term sheets, legal due diligence and employee incentives

Building biotech companies and raising venture capital financing

Raising $50M series A with Cimeio Therapeutics

Featured Portfolio news

NXI Therapeutics Expands Management Team and Board Ahead of Next Growth Stage

Basel – A Major Powerhouse in Cancer Research

Podcast: Never underestimate the true value of IP with Philipp Marchand

Anaveon presents updated data from the Phase I/II study of ANV419 during the ESMO Congress 2022

BaseLaunch and WuXi Biologics announce their partnership

Three Pillars for Setting up Biotech Startups for Success

Phialogics joins BaseLaunch Portfolio

Roivant’s growth story

BaseLaunch and Schrödinger announce their partnership

BaseLaunch’s Mission: Building Exceptional Biotech Companies

Charles River announces partnership with BaseLaunch

Featured Portfolio news

InCephalo AG Announces Appointment of Lauren E. Abrey, MD as Chief Medical Officer

How Lonza’s Ibex® Design 2.0 Program Accelerates Time to IND

Value-based pricing in pharmaceuticals – hype or hope?

Wuxi AppTec partnership with BaseLaunch renewal

All Uncategorized

Switzerland is #1 in biotech globally according to a nature biotech study

Accessing TCR Discovery Capabilities with Alloy Therapeutics

All Uncategorized

BaseLaunch Summer Get-Toghether 2022

Lonza announces collaboration with BaseLaunch

14 legal questions every biotech startup should ask

Anaveon_-startups_Switzerland-credit-Jasmin-Rei

Anaveon announces starting efficacy trials with ANV419, their powerful and selective IL-2 agonist.

Onena Medicines joins BaseLaunch Portfolio

Engimmune Therapeutics raises $16.7M in seed financing co-led by Pureos Bioventures and Novo Holdings

Cimeio Therapeutics raises a 50M USD series A financing from Versant Ventures

File or fail in the age of publish or perish

Your first European launch: a prescription for growth

BaseLaunch – onwards and upwards

Do you have a question? Get in touch

info@baselaunch.ch

© 2023 BaselArea